Physician profile
David M Troendle
NPI 1639373053
$13,757.24
in general payments reported to CMS, 2019-2025
23 companies · $10K in 2025
The $10K reported for 2025 was more than what 93% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $15.09 · 2021: $51.10 · 2022: $131 · 2023: $281 · 2024: $2,414 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,158 · Travel and Lodging: $3,504 · Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,157.95 |
| Travel and Lodging | $3,504.01 |
| Food and Beverage | $1,524.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $6,898.13 | 2025 | |
| Olympus Medical Systems Corporation | $3,913.83 | 2024-2025 | Evis Exera III Duodenovideoscope |
| Evoendo, INC | $850.00 | 2025 | |
| 3-D Matrix, INC. | $705.19 | 2024-2025 | |
| Medtronic, INC. | $334.60 | 2023-2024 | Endoflip |
| Abbvie INC. | $209.65 | 2019-2025 | |
| Conmed Corporation | $164.55 | 2019 | |
| Ethicon US, LLC | $130.36 | 2024-2025 | Echelon; Endopath, Ethicon, Echelon Flex |
| Olympus America INC. | $79.96 | 2022 | |
| Qol Medical, LLC | $76.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.19 | 2024 | Eohilia |
| Boston Scientific Corporation | $51.44 | 2022 | |
| Stryker Corporation | $45.38 | 2023 | Chromophare F300 |
| Alexion Pharmaceuticals, INC. | $44.96 | 2019 | |
| Pharming Healthcare, INC. | $33.40 | 2023-2024 | Ruconest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $26.55 | 2023 | Daybue |
| Medical Device Business Services, INC. | $25.14 | 2025 | Echelon Flex |
| Mauna Kea Technologies, INC. | $23.86 | 2025 | |
| Erbe USA INC | $21.35 | 2024 | |
| Janssen Biotech, INC. | $20.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.84 | 2023 | Dupixent |
| Cumberland Pharmaceuticals, INC. | $15.09 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Troendle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.